Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 26, Issue 7, Pages 1677-1684
Publisher
Informa Healthcare
Online
2010-05-13
DOI
10.1185/03007995.2010.483941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study
- (2009) Craig Hartrick et al. CLINICAL THERAPEUTICS
- A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
- (2009) Stephen Daniels et al. CURRENT MEDICAL RESEARCH AND OPINION
- A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
- (2009) Stephen E. Daniels et al. CURRENT MEDICAL RESEARCH AND OPINION
- Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study
- (2009) Martin Hale et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain
- (2009) R. Buynak et al. JOURNAL OF PAIN
- Management of opioid medications in patients with chronic pain and risk of substance misuse
- (2009) Seddon R. Savage Current Psychiatry Reports
- What is the Case for Prescribing Long-Acting Opioids Over Short-Acting Opioids for Patients with Chronic Pain? A Critical Review
- (2009) Richard L. Rauck Pain Practice
- Single Dose Analgesic Efficacy of Tapentadol in Postsurgical Dental Pain: The Results of a Randomized, Double-Blind, Placebo-Controlled Study
- (2008) Regina Kleinert et al. ANESTHESIA AND ANALGESIA
- The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery
- (2008) Jens-Ulrich Stegmann et al. CURRENT MEDICAL RESEARCH AND OPINION
- A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation
- (2008) Winfried Meissner et al. EUROPEAN JOURNAL OF PAIN
- Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain
- (2008) J. Nadstawek et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia
- (2008) Anna Vardanyan et al. JOURNAL OF PAIN
- Patient Barriers to Pain Management May Contribute to Poor Pain Control in Rheumatoid Arthritis
- (2008) Mary-Ann Fitzcharles et al. JOURNAL OF PAIN
- Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness
- (2008) Jay Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
- (2008) Lynn Webster et al. PAIN
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)
- (2008) Timothy J. Bell et al. PAIN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now